Skip to Content

Coartem Approval History

  • FDA approved: Yes (First approved April 7th, 2009)
  • Brand name: Coartem
  • Generic name: artemether and lumefantrine
  • Dosage form: Tablets
  • Company: Novartis
  • Treatment for: Malaria

Coartem (artemether and lumefantrine) is an artemisinin-based combination treatment for the treatment of malaria.

Development History and FDA Approval Process for Coartem

Apr  8, 2009Approval Coartem receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.